Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Curr Med Chem ; 19(16): 2572-87, 2012.
Article in English | MEDLINE | ID: mdl-22489714

ABSTRACT

Coronary artery disease (CAD) is the leading cause of mortality in Western Societies and several developing countries. Recent evidence suggests that most detrimental clinical manifestations of CAD, such as acute coronary syndromes (ACS), are the outcome of inflammatory processes that lead to plaque formation and rupture and eventually to ischemia and potentially myocardial necrosis. Neither of the traditionally used biomarkers is thought to be the gold standard in detection of myocardial ischemia or necrosis. A biomarker that could detect quite early the ischemic myocardium as well as define the risk of a future event with high sensitivity and specificity is still lacking. Several biomarkers, implicated in the pathogenesis and clinical evolution of atherosclerosis, have emerged as potent biomarkers for early detection of myocardial ischemia. In the current review, we summarize recent evidence of the most promising biomarkers and discuss their potential role in clinical practice in patients suffering from ACSs.


Subject(s)
Acute Coronary Syndrome/metabolism , Biomarkers/metabolism , Humans , Inflammation/metabolism , Myocardial Ischemia/metabolism , Oxidative Stress
2.
Curr Med Chem ; 19(16): 2548-54, 2012.
Article in English | MEDLINE | ID: mdl-22489716

ABSTRACT

Calcific aortic valve disease is a common disease in the elderly associated with significant morbidity and mortality. It was once described as a passive degenerative process during which serum calcium attaches to the valve surface and binds to the leaflet. However, during the last decade mounting evidence demonstrated that this disease has an active biologic process with numerous signaling pathways. The histological hallmarks seem to be inflammation, oxidized lipids-also detectable in aortic valve lesions-and a remodeling of the extracellular matrix leading to bone formation. Over the years, growing evidence has indicated the risk factors for calcific aortic stenosis including lipids, hypertension, male gender, renal failure, and diabetes. Additional monitoring tools, such as molecular imaging, could improve risk stratification, while assessment of severity and prognosis of patients with chronic aortic regurgitation, is desirable. Also, several studies have investigated the role of biomarkers regarding their utility in the screening of calcific aortic valve disease and their putative clinical value, though their role still remains undetermined.


Subject(s)
Aortic Valve Stenosis/metabolism , Biomarkers/metabolism , Calcinosis/metabolism , Aortic Valve Stenosis/diagnosis , Aortic Valve Stenosis/physiopathology , Calcinosis/diagnosis , Calcinosis/physiopathology , Cardiac Imaging Techniques , Humans , Risk Factors
3.
Curr Med Chem ; 19(16): 2597-604, 2012.
Article in English | MEDLINE | ID: mdl-22489718

ABSTRACT

Experimental studies suggest that bone marrow-derived endothelial progenitor cells (EPCs) play an important role in the maintenance of endothelial integrity and hemostasis. The number of circulating EPC has been shown to be inversely correlated with cardiovascular risk factors and vascular function and to predict cardiovascular events independent of both traditional and non-traditional risk factors. Thus, EPCs provide a clinical advantage over the use of other biomarkers as their measurement is directly associated with endothelial function, and available evidence suggests that they are consistently and significantly associated with a spectrum of cardiovascular complications, such as acute coronary syndromes and coronary artery disease. However, many issues in the field of EPC isolation and identification, particularly in regards to the effective and unequivocal molecular characterization of these cells still remain unresolved. In addition, simple EPC counts do not adequately describe cardiovascular disease risk. This limitation is attributable to variation in the definition of EPCs, the number of existing cardiovascular risk factors in different patients as well as a difference in the interaction between EPCs and other hematopoietic progenitor, inflammatory cells or platelets.


Subject(s)
Cardiovascular Diseases/pathology , Endothelial Cells/pathology , Stem Cells/pathology , Animals , Biomarkers , Humans , Risk Factors
4.
Clin Microbiol Infect ; 9(12): 1234-7, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14686990

ABSTRACT

Bacillus cereus is a food-borne pathogen that causes a self-limiting gastroenteritis. We describe the case of a 72-year-old woman admitted to our hospital because of acute abdominal colic pain. Over a 2-day period, her clinical condition deteriorated rapidly, with the appearance of acute abdomen. Computed tomography investigation of the abdomen showed a liver abscess (diameter approximately 3 cm). At laparotomy, the abscess was found to be ruptured to the free peritoneal cavity. The final clinical diagnosis was acute peritonitis due to a ruptured liver abscess. Bacillus cereus was isolated from culture of the pus. Up to now, no case of liver abscess due to this organism has been reported.


Subject(s)
Abdomen, Acute/complications , Bacillus cereus/growth & development , Gram-Positive Bacterial Infections/complications , Liver Abscess/microbiology , Abdomen, Acute/microbiology , Abdomen, Acute/surgery , Aged , Fatal Outcome , Female , Gram-Positive Bacterial Infections/microbiology , Humans , Laparotomy , Liver Abscess/surgery
5.
Int J Clin Pharmacol Res ; 22(3-4): 85-8, 2002.
Article in English | MEDLINE | ID: mdl-12837045

ABSTRACT

In the present study, we investigated the effects of a 6-month treatment with orlistat on body weight and lipid profile in 27 overweight women (mean body mass index [BMI]: 27.5 kg/m2; median age: 38.4 years) with mild hypercholesterolemia (total cholesterol: 225 mg/dl; low-density lipoprotein cholesterol [LDL-C]: 162 mg/dl). Orlistat was administered three times per day in conjunction with a hypocaloric diet After 6 months of treatment, body weight decreased by 17.71% and BMI decreased by 18.54%, whereas there was a significant (p < 0.01) improvement in serum lipid levels (total cholesterol: -25.33% LDL-C: -30.86%, high-density lipoprotein cholesterol: +9.37%, triglycerides: -35.97%). In conclusion, orlistat in combination with a low-energy diet seems to have a beneficial effect on body weight and lipid profile in overweight women with mild hypercholesterolemia.


Subject(s)
Anti-Obesity Agents/therapeutic use , Hypercholesterolemia/drug therapy , Lactones/therapeutic use , Obesity/drug therapy , Adult , Anti-Obesity Agents/administration & dosage , Body Mass Index , Body Weight/drug effects , Cholesterol, LDL/blood , Diet, Reducing , Female , Humans , Hypercholesterolemia/complications , Hypercholesterolemia/diet therapy , Lactones/administration & dosage , Lipoproteins, HDL/blood , Middle Aged , Obesity/complications , Obesity/diet therapy , Orlistat , Treatment Outcome , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...